Oxford BioMedica (OXBDF) News Today $4.28 0.00 (0.00%) As of 06/23/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock OXBDF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Oxford BioMedica completes purchase of last 10% stake in US subsidiaryJune 23 at 8:12 AM | lse.co.ukOxford BioMedica (OTCMKTS:OXBDF) Trading Down 8.2% - What's Next?June 19, 2025 | marketbeat.comOxford BioMedica touts strong first-half momentum ahead of meetingJune 11, 2025 | lse.co.ukOxford Biomedica (OTCMKTS:OXBDF) Trading 18.7% Higher - Here's What HappenedMay 31, 2025 | marketbeat.comOxford Biomedica plc (OTCMKTS:OXBDF) Sees Significant Growth in Short InterestMay 5, 2025 | marketbeat.comOxford Biomedica Full Year 2024 Earnings: EPS Beats ExpectationsMay 1, 2025 | finance.yahoo.comOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 83.5% in MarchApril 20, 2025 | marketbeat.comOxford BioMedica (OXBDF) Receives a Buy from RBC CapitalApril 15, 2025 | theglobeandmail.comWhen Will Oxford Biomedica plc (LON:OXB) Turn A Profit?April 10, 2025 | uk.finance.yahoo.comOxford Biomedica sees FY25 revenue GBP 160M-GBP 170MApril 9, 2025 | msn.comOxford Biomedica prepares statements on ‘going concern basis’April 9, 2025 | msn.comOxford Biomedica plc (OXBDF) Q4 2024 Earnings Call TranscriptApril 9, 2025 | seekingalpha.comOxford Biomedica annual loss narrows; hails "commercial momentum"April 9, 2025 | lse.co.ukOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 71.9% in MarchMarch 30, 2025 | marketbeat.comOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 131.0% in FebruaryMarch 14, 2025 | marketbeat.comOxford Biomedica plc (OTCMKTS:OXBDF) Sees Large Growth in Short InterestMarch 2, 2025 | marketbeat.comOxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trialFebruary 20, 2025 | markets.businessinsider.comOxford Biomedica (OTCMKTS:OXBDF) Stock Price Down 0.9% - What's Next?February 10, 2025 | marketbeat.comOxford Biomedica appoints joint corporate broker, joint financial advisorFebruary 5, 2025 | markets.businessinsider.comOxford Biomedica Announces Total Voting Rights for 2024January 2, 2025 | markets.businessinsider.comOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest UpdateDecember 26, 2024 | marketbeat.comOxford Biomedica Announces Total Voting RightsDecember 2, 2024 | markets.businessinsider.comOxford Biomedica Aligns Executive Incentives with GoalsNovember 23, 2024 | markets.businessinsider.comOxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorganOctober 29, 2024 | markets.businessinsider.comOxford Biomedica Seeks Stock Market ExpansionOctober 22, 2024 | markets.businessinsider.comShort Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Drops By 66.7%October 10, 2024 | marketbeat.comRBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)September 27, 2024 | markets.businessinsider.comOxford BioMedica: A Strong Buy on Undervaluation and Promising Growth ProspectsSeptember 24, 2024 | markets.businessinsider.comOxford Biomedica posts strong revenue growth in first half resultsSeptember 23, 2024 | msn.comOxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMOSeptember 18, 2024 | globenewswire.comLucinda Crabtree joins Oxford Biomedica as Chief Financial Officer todaySeptember 2, 2024 | globenewswire.comOxford Biomedica plc (OXBDF)August 18, 2024 | finance.yahoo.comOxford Biomedica – Half Year Trading Update and Notice of Interim ResultsAugust 8, 2024 | markets.businessinsider.comOxford Biomedica announces CFO transitionJuly 17, 2024 | globenewswire.comOxford Biomedica Full Year 2023 Earnings: Misses ExpectationsMay 1, 2024 | finance.yahoo.comOxford Biomedica plc GAAP EPS of -163.11p, revenue of £89.5MApril 30, 2024 | msn.comSMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumpsApril 29, 2024 | lse.co.ukOxford BioMedica PLCApril 20, 2024 | barrons.comOxford Biomedica Insiders Placed Bullish Bets Worth UK£415.3kMarch 30, 2024 | finance.yahoo.comOxford BioMedica PLC (OXB)January 23, 2024 | investing.comOxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturingJanuary 23, 2024 | finance.yahoo.comOxford BioMedica PLC OXOANovember 4, 2023 | morningstar.comMAnalysts Just Slashed Their Oxford Biomedica plc (LON:OXB) EPS NumbersSeptember 25, 2023 | finance.yahoo.comOxford Biomedica (OTCMKTS:OXBDF) Price Target Cut to GBX 325 by Analysts at JPMorgan Chase & Co.September 22, 2023 | marketbeat.comOxford BioMedica shares boom as manufacturer expands complex cancer therapiesSeptember 21, 2023 | msn.comOxford BioMedica shares up, in talks to buy ABL Europe but loss widensSeptember 20, 2023 | lse.co.ukOxford Biomedica stock soars on rosy forecast, talks to buy ABL EuropeSeptember 20, 2023 | msn.comOxford BioMedica Shares Rise on Transformational Deal Talks, Revenue Growth ExpectationSeptember 20, 2023 | marketwatch.comOxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformationSeptember 20, 2023 | finance.yahoo.comKyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® PlatformSeptember 20, 2023 | finance.yahoo.com Get Oxford BioMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter. Email Address OXBDF Media Mentions By Week OXBDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXBDF News Sentiment▼0.000.59▲Average Medical News Sentiment OXBDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXBDF Articles This Week▼20▲OXBDF Articles Average Week Get Oxford BioMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APELY News DNACF News SHALY News SFSHF News OUTKY News PHMMF News HCHDF News CSIOY News SSPPF News PALAF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OXBDF) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto America27 of crypto's most successful minds are about to pull back the curtain… Bitcoin has crushed its all-time h...Crypto 101 Media | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioMedica Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OXBDF Stock Free OXBDF Stock Alerts